Full Committee Hearing Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
Witnesses
Panel I
-
Dr.
Beth
Bell
Director, National Center for Emerging and Zoonotic Infectious DiseasesCenters for Disease Control and PreventionAtlanta, GA
- Adobe Acrobat DocumentDownload Testimony
-
Dr.
Peggy
Hamburg
CommissionerFood and Drug AdministrationWashington, DC
- Adobe Acrobat DocumentDownload Testimony
-
Dr.
Lauren
Smith
Interim CommissionerDepartment of Public HealthBoston, MA
- Adobe Acrobat DocumentDownload Testimony
Panel II
-
Barry
Cadden
Owner and Director of PharmacyNew England Compounding CenterFramingham, MA
Panel III
-
Dr.
Marion
Kainer
DirectorHealthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of HealthNashville, TN
- Adobe Acrobat DocumentDownload Testimony
-
David G.
Miller
Executive Vice President and CEOInternational Academy of Compounding PharmacyMissouri City, TX
- Adobe Acrobat DocumentDownload Testimony
-
Dr.
Kasey K.
Thompson
Vice President, Office of Policy, Planning and CommunicationsAmerican Society of Health-System PharmacistsBethesda, MD
- Adobe Acrobat DocumentDownload Testimony
Transcripts
Related Files
Other Files
- Adobe Acrobat DocumentHELP Staff Report on Meningitis Outbreak
- Adobe Acrobat DocumentAttachments